scholarly journals Using two phases of the CD 4 T cell response to blood‐stage murine malaria to understand regulation of systemic immunity and placental pathology in Plasmodium falciparum infection

2020 ◽  
Vol 293 (1) ◽  
pp. 88-114 ◽  
Author(s):  
Komi Gbedande ◽  
Victor H. Carpio ◽  
Robin Stephens
2018 ◽  
Vol 218 (7) ◽  
pp. 1119-1129 ◽  
Author(s):  
Chelsea L Edwards ◽  
Susanna S Ng ◽  
Dillon Corvino ◽  
Marcela Montes de Oca ◽  
Fabian de Labastida Rivera ◽  
...  

PLoS ONE ◽  
2011 ◽  
Vol 6 (7) ◽  
pp. e22434 ◽  
Author(s):  
Sandra Marcia Muxel ◽  
Ana Paula Freitas do Rosário ◽  
Cláudia Augusta Zago ◽  
Sheyla Inés Castillo-Méndez ◽  
Luiz Roberto Sardinha ◽  
...  

Gene Therapy ◽  
2007 ◽  
Vol 14 (20) ◽  
pp. 1481-1491
Author(s):  
S Cayeux ◽  
B Bukarica ◽  
C Buschow ◽  
J Charo ◽  
M Bunse ◽  
...  

Author(s):  
T.G. Theander ◽  
I.C. Bygbjerg ◽  
L. Jacobsen ◽  
S. Jepsen ◽  
P.B. Larsen ◽  
...  

1997 ◽  
Vol 114 (1) ◽  
pp. 15-22 ◽  
Author(s):  
Nobuo Ohta ◽  
Kimiko Iwaki ◽  
Makoto Itoh ◽  
Jun Fu ◽  
Shigeko Nakashima ◽  
...  

2015 ◽  
Vol 17 (1) ◽  
pp. 130-139 ◽  
Author(s):  
Alexander D. Douglas ◽  
G. Christian Baldeviano ◽  
Carmen M. Lucas ◽  
Luis A. Lugo-Roman ◽  
Cécile Crosnier ◽  
...  

2013 ◽  
Vol 191 (1) ◽  
pp. 178-186 ◽  
Author(s):  
Taiping Liu ◽  
Guilian Xu ◽  
Bo Guo ◽  
Yong Fu ◽  
Yuan Qiu ◽  
...  

2010 ◽  
Vol 17 (11) ◽  
pp. 1687-1694 ◽  
Author(s):  
Katarina Radošević ◽  
Ariane Rodriguez ◽  
Angelique A. C. Lemckert ◽  
Marjolein van der Meer ◽  
Gert Gillissen ◽  
...  

ABSTRACT The most advanced malaria vaccine, RTS,S, is comprised of an adjuvant portion of the Plasmodium falciparum circumsporozoite (CS) protein fused to and admixed with the hepatitis B virus surface antigen. This vaccine confers short-term protection against malaria infection, with an efficacy of about 50%, and induces particularly B-cell and CD4+ T-cell responses. In the present study, we tested by the hypothesis that the Th1 immune response to CS protein, in particular the CD8+ T-cell response, which is needed for strong and lasting malaria immunity, is boosted to sustainable levels vectors adenovirus and 26 with an homologous insert 35 (Ad35.CS/Ad26.CS). In this study, we evaluated immune responses induced with vaccination regimens based on an adjuvant-containing, yeast-produced complete CS protein followed by two recombinant low-seroprevalence adenoviruses expressing P. falciparum CS antigen, Ad35.CS (subgroup B) and Ad26.CS (subgroup D). Our results show that (i) the yeast (Hansenula polymorpha)produced, adjuvanted full-length CS protein is highly potent in inducing high CS-specific humoral responses in mice but produces poor T-cell responses, (ii) the Ad35.CS vector boosts the gamma interferon-positive (IFN-γ+) CD8+ T-cell response induced by the CS protein immunization and shifts the immune response toward the Th1 type, and (iii) a three-component heterologous vaccination comprised of a CS protein prime followed by boosts with Ad35.CS and Ad26.CS elicits an even more robust and sustainable IFN-γ+ CD8+ T-cell response than one- or two-component regimens. The Ad35.CS/Ad26.CS combination boosted particularly the IFN-γ+ and tumor necrosis factor alpha-positive (TNF-α+) T cells, confirming the shift of the immune response from the Th2 type to the Th1 type. These results support the notion of first immunizations of infants with an adjuvanted CS protein vaccine, followed by a booster Ad35.CS/Ad26.CS vaccine at a later age, to induce lasting protection against malaria for which the Th1 response and immune memory is required.


Sign in / Sign up

Export Citation Format

Share Document